HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers.

AbstractBACKGROUND:
Pentraxin 3 (PTX3) influences innate immunity and inflammation, host defence, the complement cascade and angiogenesis. PTX3 expression in lung and blood of subjects with tobacco exposure, and its potential relationship with disease pattern and clinical outcome are poorly understood.
METHODS:
Using independent platforms and cohorts, we identified associations of PTX3 gene expression in lung tissue and plasma from current and former tobacco smokers (with and without chronic obstructive pulmonary disease, COPD) to disease phenotypes including quantitative CT determined emphysema, lung function, symptoms and survival. Two putative regulatory variants of the PTX3 gene were examined for association with COPD manifestations. The relationship between plasma PTX3 and hyaluronic acid levels was further examined.
RESULTS:
PTX3 gene expression in lung tissue was directly correlated with emphysema severity (p<0.0001). Circulating levels of PTX3 were inversely correlated with FEV1 (p=0.006), and positively associated with emphysema severity (p=0.004) and mortality (p=0.008). Two PTX3 gene regulatory variants were associated with a lower risk for emphysema and expiratory airflow obstruction, and plasma levels of PTX3 and hyaluronic acid were related.
CONCLUSIONS:
These data show strong and overlapping associations of lung and blood PTX3 levels, and PTX3 regulatory gene variants, with the severity of airflow obstruction, emphysema and mortality among smokers. These findings have potential implications regarding the pathogenesis of smoking-related lung diseases and warrant further exploration for the use of PTX3 as a predictive biomarker.
AuthorsYingze Zhang, John Tedrow, Mehdi Nouraie, Xiaoyun Li, Divay Chandra, Jessica Bon, Daniel J Kass, Carl R Fuhrman, Joseph K Leader, Steven R Duncan, Naftali Kaminski, Frank C Sciurba
JournalThorax (Thorax) Vol. 76 Issue 4 Pg. 335-342 (04 2021) ISSN: 1468-3296 [Electronic] England
PMID33479043 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Chemical References
  • Biomarkers
  • Serum Amyloid P-Component
  • PTX3 protein
  • Hyaluronic Acid
  • C-Reactive Protein
Topics
  • Adult
  • Aged
  • Biomarkers (metabolism)
  • C-Reactive Protein (genetics, metabolism)
  • Female
  • Gene Expression
  • Humans
  • Hyaluronic Acid (metabolism)
  • Male
  • Middle Aged
  • Phenotype
  • Pulmonary Disease, Chronic Obstructive (metabolism)
  • Pulmonary Emphysema (metabolism, mortality, physiopathology)
  • Respiratory Function Tests
  • Serum Amyloid P-Component (genetics, metabolism)
  • Smokers
  • Survival Rate
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: